Services for cardiovascular diseases | Upazila health complex, n (%) | Union-level public facilities, n (%) | Community clinic, n (%) | Private facilities, n (%) | Total n (%) | P-value |
---|---|---|---|---|---|---|
Overall | 9 (7.1) | 36 (28.6) | 53 (42.1) | 28 (22.2) | 126 (100) | Â |
Staff and guidelines | ||||||
 Guidelines on the diagnosis and treatment | 6 (66.7) | 9 (25.0) | 13 (24.5) | 15 (53.6) | 43 (34.1) |  |
 At least one trained staff member (within 24 months) | 5 (55.6) | 4 (11.1) | 5 (9.4) | 5 (17.9) | 19 (15.1) |  |
Mean (± SD) | 61.2 (± 7.8) | 18.1 (± 9.8) | 17.0 (± 10.7) | 35.8 (± 25.2) | 24.6 (± 13.4) | 0.124 |
Basic equipment | ||||||
 Blood pressure apparatus | 9 (100) | 36 (100) | 47 (88.7) | 28 (100) | 120 (95.2) |  |
 Stethoscope | 9 (100) | 36 (100) | 47 (88.7) | 28 (100) | 120 (95.2) |  |
 Adult scale | 7 (77.8) | 19 (52.8) | 38 (71.7) | 25 (89.3) | 89 (70.6) |  |
 Thermometer | 9 (100) | 30 (83.3) | 50 (94.3) | 28 (100.0) | 117 (92.9) |  |
 BMI calculator | 8 (88.9) | 0 | 0 | 8 (28.6) | 16 (12.7) |  |
Mean(± SD) | 92.6 (± 9.1) | 66.7 (± 37.8) | 67.9 (± 35.2) | 83.9 (± 27.8) | 72.9 (± 31.7) | 0.708 |
Diagnostic facility | ||||||
 Blood lipids | 0 | 0 | 0 | 0 | 0 |  |
 Electrolytes potassium | 0 | 0 | 0 | 0 | 0 |  |
Mean (± SD) | N/A | N/A | N/A | N/A | N/A | N/A |
Essential medicines | ||||||
 Atenolol | 7 (77.8) | 0 | 0 | 0 | 7 (5.6) |  |
 Digoxin | 4 (44.4) | 0 | 0 | 0 | 4 (3.2) |  |
 Enalapril | 3 (33.3) | 0 | 0 | 0 | 3 (2.4) |  |
 Furosemide | 4 (44.4) | 0 | 0 | 0 | 4 (3.2) |  |
 Glyceryl trinitrate | 0 | 0 | 0 | 0 | 0 |  |
 Isosorbide dinitrate | 0 | 0 | 0 | 0 | 0 |  |
 Nifedipine | 2 (22.2) | 0 | 0 | 0 | 2 (1.6) |  |
 Methyldopa | 3 (33.3) | 0 | 0 | 0 | 3 (2.4) |  |
 Procainamide | 0 | 0 | 0 | 0 | 0 |  |
 Propranolol | 2 (22.2) | 0 | 0 | 0 | 2 (1.6) |  |
 Spironolactone | 2 (22.2) | 0 | 0 | 0 | 2 (1.6) |  |
 Verapamil | 0 | 0 | 0 | 0 | 0 |  |
 Warfarin | 0 | 0 | 0 | 0 | 0 |  |
Mean (± SD) | 23.1 (± 23.8) | N/A | N/A | N/A | 1.7 (± 1.7) |  < 0 .001 |